W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
UI
MeSH Term
Description
Entries
D009626
Terminology as Topic
Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.
Leukotriene
Related Publications
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
June 2016,
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey
W L Smith, and
P Borgeat, and
M Hamberg, and
L J Roberts, and
A l Willis, and
S Yamamoto, and
P W Ramwell, and
J Rokach, and
B Samuelsson, and
E J Corey